{"id":607243,"date":"2025-12-02T05:14:34","date_gmt":"2025-12-02T13:14:34","guid":{"rendered":"https:\/\/nai500.com\/?p=607243"},"modified":"2025-12-02T05:14:34","modified_gmt":"2025-12-02T13:14:34","slug":"%e4%b8%8b%e4%b8%80%e4%b8%aa%e9%87%8d%e7%a3%85%e8%8d%af%e7%89%a9%e4%bc%9a%e6%9d%a5%e8%87%aa%e4%b8%ad%e5%9b%bd%e5%90%97%ef%bc%9f","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2025\/12\/%e4%b8%8b%e4%b8%80%e4%b8%aa%e9%87%8d%e7%a3%85%e8%8d%af%e7%89%a9%e4%bc%9a%e6%9d%a5%e8%87%aa%e4%b8%ad%e5%9b%bd%e5%90%97%ef%bc%9f\/","title":{"rendered":"\u4e0b\u4e00\u4e2a\u91cd\u78c5\u836f\u7269\u4f1a\u6765\u81ea\u4e2d\u56fd\u5417\uff1f"},"content":{"rendered":"<p>\u4e00\u6ce2\u65b0\u7684\u4e2d\u56fd\u5236\u836f\u4f01\u4e1a\u6b63\u4ece\u5feb\u901f\u8ddf\u968f\u8005\u8f6c\u5411\u9996\u521b\u8005\u3002\u7ecf\u8fc7\u591a\u5e74\u7684\u6295\u8d44\u5468\u671f\u3001\u76d1\u7ba1\u5347\u7ea7\u4ee5\u53ca\u4f9b\u5e94\u94fe\u7684\u5e38\u6001\u5316\uff0c\u4e2d\u56fd\u7684\u751f\u7269\u5236\u836f\u673a\u5668\u5df2\u5177\u5907\u5168\u7403\u5316\u8fd0\u4f5c\u80fd\u529b\u3002\u95ee\u9898\u4e0d\u518d\u770b\u8d77\u6765\u662f\u5047\u8bbe\u6027\u7684\uff1a\u4e0b\u4e00\u6b3e\u91cd\u78c5\u836f\u7269\u53ef\u80fd\u5728\u4e0a\u6d77\u88ab\u53d1\u73b0\uff0c\u5728\u4e9a\u6d32\u5f00\u5c55\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5728\u82cf\u5dde\u751f\u4ea7\uff0c\u5e76\u4ee5 FDA \u548c EMA \u6807\u7b7e\u4e0a\u5e02\u3002\u5982\u679c\u4f60\u662f\u5173\u6ce8\u53ef\u6301\u7eed\u589e\u957f\u548c\u73b0\u91d1\u6d41\u62a4\u57ce\u6cb3\u7684\u6295\u8d44\u8005\uff0c\u8fd9\u4e0d\u662f\u5c0f\u4f17\u6545\u4e8b\u3002\u8fd9\u662f\u4e00\u79cd\u6db5\u76d6\u53d1\u73b0\u3001\u4e34\u5e8a\u548c CDMO \u7684\u53ef\u5e7f\u6cdb\u51fa\u53e3\u7684\u80fd\u529b\uff0c\u5bf9\u5b9a\u4ef7\u6743\u548c\u65b0\u5174\u5e02\u573a\u53ef\u53ca\u6027\u5177\u6709\u6df1\u8fdc\u5f71\u54cd\u3002<\/p>\n<h3>\u4e2d\u56fd\u751f\u7269\u79d1\u6280\u7684\u89c4\u6a21\u9047\u4e0a\u901f\u5ea6<\/h3>\n<p>\u5317\u4eac\u7684\u653f\u7b56\u6846\u67b6\u73b0\u5728\u5956\u52b1\u201c\u5feb\u901f\u8fbe\u6210\u8d28\u91cf\u201d\u3002NMPA \u7684\u6539\u9769\u3001\u4e0e ICH \u7684\u5bf9\u9f50\u4ee5\u53ca Marketing Authorization Holder \u5236\u5ea6\u538b\u7f29\u4e86\u65f6\u95f4\u7ebf\uff0c\u63a8\u52a8\u516c\u53f8\u65e9\u671f\u8fbe\u5230 FDA \u548c EMA \u6807\u51c6\u3002\u8fd9\u52a0\u901f\u4e86\u8de8\u5883\u5ba1\u6279\u548c\u5bf9\u5916\u6388\u6743\u3002\u5728\u57fa\u5c42\uff0c\u4e16\u754c\u7ea7\u7684\u5de5\u7a0b\u80fd\u529b\u5df2\u8f6c\u5316\u4e3a\u4ea7\u51fa\u80fd\u529b\u3002WuXi AppTec (SSE: 603259; HKEX: 2359) \u6784\u5efa\u4e86\u8d2f\u7a7f\u53d1\u73b0\u3001\u5f00\u53d1\u548c\u5236\u9020\u7684\u7aef\u5230\u7aef\u5e73\u53f0\u3002\u5176\u7ea6 39,000 \u540d\u5458\u5de5\u30016,000 \u4e2a\u5ba2\u6237\u4ee5\u53ca\u8986\u76d6\u4e2d\u56fd\u3001\u7f8e\u56fd\u3001\u5fb7\u56fd\u3001\u745e\u58eb\u548c\u65b0\u52a0\u5761\u7684\u7f51\u7edc\uff0c\u4e3a\u4efb\u4f55\u751f\u7269\u6280\u672f\u516c\u53f8\u63d0\u4f9b\u4e86\u5373\u65f6\u7684\u5168\u7403\u8db3\u8ff9\u3002\u4e34\u5e8a\u8bd5\u9a8c\u8d28\u91cf\u4e5f\u5728\u8d76\u4e0a\uff0c\u5f97\u76ca\u4e8e\u4e0a\u6d77\u3001\u82cf\u5dde\u3001\u5e7f\u5dde\u548c\u5317\u4eac\u7684\u533b\u9662\u7f51\u7edc\uff0c\u4ee5\u53ca\u964d\u4f4e\u4e0a\u5e02\u540e\u7814\u7a76\u98ce\u9669\u7684\u771f\u5b9e\u4e16\u754c\u6570\u636e\u8bd5\u70b9\u3002\u6700\u7ec8\u6548\u679c\u662f\u5f62\u6210\u4e86\u4e00\u4e2a\u80fd\u591f\u5728\u4e0d\u8d70\u6377\u5f84\u7684\u60c5\u51b5\u4e0b\u538b\u7f29\u7814\u53d1\u5468\u671f\u7684\u56fd\u5185\u751f\u6001\u7cfb\u7edf\uff0c\u4ee5\u53ca\u4e00\u4e2a\u73b0\u5728\u6210\u4e3a\u7ade\u4e89\u4f18\u52bf\u800c\u975e\u75ab\u60c5\u65f6\u4ee3\u74f6\u9888\u7684\u4f9b\u5e94\u94fe\u3002<\/p>\n<h3>\u653f\u7b56\u987a\u98ce\u4e0e FDA \u52a8\u80fd<\/h3>\n<p>\u7814\u53d1\u7ba1\u7ebf\u5f00\u59cb\u83b7\u5f97\u897f\u65b9\u6807\u7b7e\u3002BeiGene \u7684 Brukinsa \u83b7\u5f97\u591a\u6b21 FDA \u6279\u51c6\uff0c\u6700\u7ec8\u5728 2023 \u5e74\u56e0\u5728\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\u4e2d\u7684\u5ba1\u6279\u83b7\u6279\uff1b\u5176\u5728\u4e0e ibrutinib \u7684\u6b63\u9762\u6bd4\u8f83\u7814\u7a76\u4e2d\u663e\u793a\u66f4\u4f18\u7597\u6548\uff0c\u4ece\u800c\u6539\u53d8\u4e86\u4e34\u5e8a\u533b\u751f\u7684\u5904\u65b9\u884c\u4e3a\u3002Legend Biotech \u4e0e Janssen \u5171\u540c\u5f00\u53d1\u7684 CAR-T \u7597\u6cd5 Carvykti \u83b7\u5f97\u7f8e\u56fd\u6279\u51c6\u5e76\u6b63\u5728\u6269\u5927\u5728\u6b27\u6d32\u7684\u53ef\u53ca\u6027\uff0c\u8fd9\u662f\u4e2d\u56fd\u539f\u521b\u79d1\u5b66\u8f6c\u5316\u4e3a\u7f8e\u56fd\u9500\u91cf\u7684\u91cd\u8981\u91cc\u7a0b\u7891\u3002\u4e0e\u6b64\u540c\u65f6\uff0c\u5bf9\u5916\u6388\u6743\u5df2\u6210\u719f\u4e3a\u53ef\u91cd\u590d\u7684\u878d\u8d44\u5f15\u64ce\uff1a\u672c\u571f\u9886\u5148\u8005\u65e9\u671f\u5c06\u8d44\u4ea7\u8d27\u5e01\u5316\u7ed9\u5168\u7403\u5236\u836f\u516c\u53f8\uff0c\u540c\u65f6\u5728\u56fd\u5185\u6784\u5efa\u81ea\u5df1\u7684\u5546\u4e1a\u5316\u4f53\u7cfb\u3002\u8fd9\u4e0d\u4ec5\u5173\u4e4e\u836f\u7269\uff0c\u8fd8\u5173\u4e4e\u57fa\u7840\u8bbe\u65bd\u548c\u6570\u5b57\u6760\u6746\u3002\u201c\u4e00\u5e26\u4e00\u8def\u201d\u7269\u6d41\u548c China Communications Construction Company \u7684\u5168\u7403\u8d70\u5eca\u9879\u76ee\u4f7f\u751f\u7269\u5236\u5242\u51b7\u94fe\u4e0e\u4e34\u5e8a\u8bd5\u9a8c\u8fd0\u8f93\u5728\u4e9a\u6d32\u3001\u975e\u6d32\u548c\u4e2d\u4e1c\u66f4\u53ef\u9760\uff0c\u6253\u5f00\u4e86\u9ad8\u589e\u957f\u5e02\u573a\u3002\u56fd\u5bb6\u7ea7\u7684 AI \u4e0e\u4e91\u8ba1\u7b97\u80fd\u529b\u4e3a\u7814\u53d1\u56e2\u961f\u63d0\u4f9b\u66f4\u5f3a\u7684\u8fed\u4ee3\u52a8\u529b\u3002Alibaba Group \u7684\u8d85\u5927\u89c4\u6a21\u4e91\u652f\u6301\u57fa\u56e0\u7ec4\u5b66\u548c\u5316\u5b66\u9886\u57df\u7684\u6a21\u578b\u8bad\u7ec3\u4e0e\u4eff\u771f\u8ba1\u7b97\uff0c\u800c Tencent \u7684\u6570\u5b57\u5065\u5eb7\u89e6\u8fbe\u4e0e\u4e91\u5de5\u5177\u5219\u7b80\u5316\u4e86 eClinical \u5de5\u4f5c\u6d41\u3002\u89c4\u6a21\u3001\u653f\u7b56\u3001AI \u4e0e\u5206\u9500\u5f7c\u6b64\u5f3a\u5316\u3002<\/p>\n<h3>\u5f53\u524d\u503c\u5f97\u5173\u6ce8\u7684 10 \u53ea\u4e2d\u56fd\u751f\u7269\u5236\u836f\u80a1<\/h3>\n<p>1) BeiGene (NASDAQ: BGNE) \u2013 \u91cc\u7a0b\u7891\uff1aBrukinsa \u5728 2023 \u5e74\u56e0\u5728 CLL \u7684 FDA \u6279\u51c6\u800c\u53d6\u5f97\u91cd\u8981\u7a81\u7834\uff0c\u5176\u4e0e ibrutinib \u7684\u5934\u5bf9\u5934\u7814\u7a76\u663e\u793a\u51fa\u66f4\u4f18\u7684\u7597\u6548\u3002\u5168\u7403\u5f71\u54cd\uff1a\u5728 BTK \u6291\u5236\u5242\u9886\u57df\u6269\u5927\u7f8e\u6b27\u5e02\u573a\u4efd\u989d\uff0c\u51f8\u663e\u4e2d\u56fd\u5728\u91cd\u5927\u80bf\u7624\u5b66\u54c1\u7c7b\u4e2d\u9886\u5148\u7684\u80fd\u529b\u3002<\/p>\n<p>2) WuXi AppTec (SSE: 603259; HKEX: 2359) \u2013 \u91cc\u7a0b\u7891\uff1a\u6784\u5efa\u4e86\u7531 20 \u4e2a\u7ad9\u70b9\u7ec4\u6210\u7684\u5168\u7403\u7f51\u7edc\uff0c\u4e3a 6,000 \u4e2a\u5ba2\u6237\u63d0\u4f9b\u8d2f\u7a7f\u836f\u7269\u751f\u547d\u5468\u671f\u7684\u670d\u52a1\u3002\u5168\u7403\u5f71\u54cd\uff1a\u6210\u4e3a\u5168\u7403\u751f\u7269\u6280\u672f\u521b\u65b0\u7684\u4e8b\u5b9e\u6027\u652f\u67f1\uff0c\u964d\u4f4e\u4e86\u6210\u5343\u4e0a\u4e07\u9879\u76ee\u7684\u6210\u672c\u548c\u4e34\u5e8a\u542f\u52a8\u65f6\u95f4\u3002<\/p>\n<p>3) WuXi Biologics (HKEX: 2269) \u2013 \u91cc\u7a0b\u7891\uff1a\u4e2d\u56fd\u3001\u7231\u5c14\u5170\u4e0e\u5fb7\u56fd\u62e5\u6709\u591a\u5ea7\u901a\u8fc7 FDA \u4e0e EMA \u68c0\u67e5\u7684\u751f\u7269\u5236\u836f\u5382\u5e76\u5df2\u6295\u5165\u8fd0\u8425\u3002\u5168\u7403\u5f71\u54cd\uff1a\u6210\u4e3a\u5168\u7403\u6700\u5927\u7684\u4e00\u6b21\u6027\u8017\u6750\u751f\u7269\u5236\u9020\u4ea7\u80fd\u4e4b\u4e00\uff0c\u652f\u6301\u5168\u7403\u4e0a\u5e02\u7684\u5feb\u901f\u653e\u91cf\u3002<\/p>\n<p>4) Innovent Biologics (HKEX: 1801) \u2013 \u91cc\u7a0b\u7891\uff1a\u5176\u4e0e Eli Lilly \u5171\u540c\u5f00\u53d1\u7684 PD-1 \u6291\u5236\u5242 Tyvyt \u5df2\u5165\u9009\u4e2d\u56fd\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55\u5e76\u5728\u6269\u5927\u9002\u5e94\u75c7\u3002\u5168\u7403\u5f71\u54cd\uff1a\u5c55\u793a\u4e86\u4e2d\u56fd\u4e0e\u897f\u65b9\u4f19\u4f34\u5171\u5efa\u514d\u75ab\u80bf\u7624\u5b66\u54c1\u724c\u7684\u80fd\u529b\u3002<\/p>\n<p>5) Zai Lab (NASDAQ: ZLAB) \u2013 \u91cc\u7a0b\u7891\uff1a\u901a\u8fc7\u5408\u4f5c\u5728\u4e2d\u56fd\u63a8\u51fa\u591a\u6b3e\u9996\u521b\/\u5148\u4e0a\u5e02\u7597\u6cd5\uff0c\u5305\u62ec\u7528\u4e8e\u5375\u5de2\u764c\u7684 niraparib\u3002\u5168\u7403\u5f71\u54cd\uff1a\u4f5c\u4e3a\u5168\u7403\u751f\u7269\u79d1\u6280\u8fdb\u5165\u4e2d\u56fd\u7684\u53ef\u9760\u5546\u4e1a\u5316\u6865\u6881\uff0c\u52a0\u901f\u4e86\u4e16\u754c\u7b2c\u4e8c\u5927\u836f\u54c1\u5e02\u573a\u7684\u60a3\u8005\u7528\u836f\u53ef\u53ca\u6027\u3002<\/p>\n<p>6) Jiangsu Hengrui (SSE: 600276) \u2013 \u91cc\u7a0b\u7891\uff1a\u5728\u4e2d\u56fd\u5236\u836f\u4f01\u4e1a\u4e2d\u7814\u53d1\u6295\u5165\u540d\u5217\u524d\u8305\uff0c\u62e5\u6709\u5e7f\u6cdb\u7684\u6297\u80bf\u7624\u4e0e ADC \u7ba1\u7ebf\uff0c\u5e76\u5728\u7f8e\u56fd\u6709 IND \u53d7\u7406\u4e2d\u3002\u5168\u7403\u5f71\u54cd\uff1a\u4f5c\u4e3a\u9886\u5148\u7684\u672c\u571f\u521b\u65b0\u8005\uff0c\u65e5\u76ca\u901a\u8fc7\u8de8\u5883\u4ea4\u6613\u9a8c\u8bc1\u5176\u7ba1\u7ebf\u8d28\u91cf\u3002<\/p>\n<p>7) Legend Biotech (NASDAQ: LEGN) \u2013 \u91cc\u7a0b\u7891\uff1aCarvykti \u5728\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684 FDA \u6279\u51c6\uff0c\u5e76\u5728\u4e3b\u8981\u5e02\u573a\u6269\u5927\u9002\u5e94\u8bc1\u3002\u5168\u7403\u5f71\u54cd\uff1a\u5c06\u4e2d\u56fd\u8d77\u6e90\u7684\u7ec6\u80de\u6cbb\u7597\u63a8\u5411\u5168\u7403\u821e\u53f0\uff0c\u5236\u9020\u4e0e\u4f9b\u5e94\u89c4\u6a21\u5df2\u80fd\u6ee1\u8db3\u7f8e\u6b27\u9700\u6c42\u3002<\/p>\n<p>8) CSPC Pharmaceutical Group (HKEX: 1093) \u2013 \u91cc\u7a0b\u7891\uff1a2023 \u5e74\u83b7\u6279\u4e2d\u56fd\u672c\u571f\u7814\u53d1\u7684 mRNA COVID-19 \u8ffd\u52a0\u9488\u3002\u5168\u7403\u5f71\u54cd\uff1a\u5728\u65b0\u578b\u6280\u672f\u5e73\u53f0\u4e0a\u7684\u80fd\u529b\u6269\u5c55\u4e86\u4e2d\u56fd\u5728\u75ab\u82d7\u4e0e mRNA \u5e73\u53f0\u4e0a\u7684\u5b58\u5728\uff0c\u4e3a\u672a\u6765\u4f20\u67d3\u75c5\u4e0e\u80bf\u7624\u5b66\u5e94\u7528\u505a\u51c6\u5907\u3002<\/p>\n<p>9) Pharmaron (SZSE: 300759; HKEX: 3759) \u2013 \u91cc\u7a0b\u7891\uff1a\u5c06\u4e00\u4f53\u5316 CRO \u4e0e CDMO \u670d\u52a1\u6269\u5c55\u5230\u7ec6\u80de\u4e0e\u57fa\u56e0\u6cbb\u7597\uff0c\u7ad9\u70b9\u8986\u76d6\u4e2d\u56fd\u3001\u7f8e\u56fd\u4e0e\u82f1\u56fd\u3002\u5168\u7403\u5f71\u54cd\uff1a\u4f5c\u4e3a\u8de8\u5883\u5f00\u53d1\u5f15\u64ce\uff0c\u964d\u4f4e CMC \u98ce\u9669\u5e76\u52a0\u901f\u5148\u8fdb\u7597\u6cd5\u7684\u65f6\u95f4\u8868\u3002<\/p>\n<p>10) Tigermed (SZSE: 300347; HKEX: 3347) \u2013 \u91cc\u7a0b\u7891\uff1a\u5efa\u7acb\u4e86\u652f\u6301\u8de8\u5730\u533a\u591a\u4e2d\u5fc3\u80bf\u7624\u4e0e\u7f55\u89c1\u75c5\u8bd5\u9a8c\u7684\u5168\u7403\u4e34\u5e8a\u8fd0\u8425\u8db3\u8ff9\u3002\u5168\u7403\u5f71\u54cd\uff1a\u63d0\u5347\u4e86\u4e2d\u56fd\u5728\u5173\u952e\u6027\u8bd5\u9a8c\u6267\u884c\u4e2d\u7684\u89d2\u8272\uff0c\u63d0\u9ad8\u4e86\u5168\u7403\u6570\u636e\u96c6\u7684\u901f\u5ea6\u4e0e\u591a\u6837\u6027\u3002<\/p>\n<h3>AI\u3001\u4e91\u4e0e\u57fa\u7840\u8bbe\u65bd\u653e\u5927\u4f18\u52bf<\/h3>\n<p>\u4ee5 AI \u4e3a\u5148\u7684\u836f\u7269\u8bbe\u8ba1\u5df2\u4ece\u627f\u8bfa\u8d70\u5411\u751f\u4ea7\u529b\u3002\u4e2d\u56fd\u56e2\u961f\u6b63\u5728\u90e8\u7f72\u57fa\u7840\u6a21\u578b\u7528\u4e8e\u9776\u70b9\u53d1\u73b0\u3001\u7ed3\u6784\u9884\u6d4b\u548c de novo \u8bbe\u8ba1\uff0c\u538b\u7f29\u4ece\u547d\u4e2d\u5230\u5148\u5bfc\u7684\u5468\u671f\u3002\u5f97\u76ca\u4e8e\u8d85\u5927\u89c4\u6a21\u4e91\u7ecf\u6d4e\u5b66\uff0c\u56fd\u5185\u8ba1\u7b97\u8d44\u6e90\u65e2\u4fbf\u5b9c\u53c8\u5feb\u901f\u3002Alibaba \u7684\u4e91\u5806\u6808\u6b63\u79ef\u6781\u4e89\u53d6\u751f\u547d\u79d1\u5b66\u5ba2\u6237\uff0c\u63d0\u4f9b\u9762\u5411\u57fa\u56e0\u7ec4\u5b66\u4e0e\u5efa\u6a21\u7684\u5b89\u5168\u5408\u89c4\u89e3\u51b3\u65b9\u6848\uff0cTencent \u7684\u751f\u6001\u7cfb\u7edf\u5c06\u60a3\u8005\u53c2\u4e0e\u3001\u5f71\u50cf\u4e0e\u8bd5\u9a8c\u7ba1\u7406\u4e32\u8054\u6210\u95ed\u73af\u3002\u7269\u7406\u57fa\u7840\u8bbe\u65bd\u540c\u6837\u5177\u6709\u5438\u5f15\u529b\u3002\u4e0a\u6d77\u4e0e\u82cf\u5dde\u5468\u8fb9\u7684\u5236\u9020\u56ed\u533a\u914d\u5907\u4e86\u7b26\u5408\u5168\u7403 GMP \u6807\u51c6\u7684\u5148\u8fdb\u4e00\u6b21\u6027\u751f\u7269\u53cd\u5e94\u5668\u4e0e\u704c\u88c5\u5b8c\u6210\u7ebf\u3002\u8fd9\u4e9b\u7ad9\u70b9\u63a5\u5165\u5347\u7ea7\u7684\u6e2f\u53e3\u3001\u9ad8\u901f\u516c\u8def\u4e0e\u51b7\u94fe\u4ed3\u50a8\uff0c\u4f7f\u751f\u7269\u5236\u5242\u6301\u7eed\u6d41\u901a\u3002\u5982\u679c\u4f60\u60f3\u8981\u4e00\u4e2a\u89c4\u6a21\u4e0e\u8d28\u91cf\u5e76\u5b58\u7684\u6a21\u7248\uff0c\u53ef\u53c2\u8003\u8be5\u56fd\u7684\u7535\u52a8\u8f66\u884c\u4e1a\uff1aBYD \u5411\u4e16\u754c\u5c55\u793a\u4e86\u4e2d\u56fd\u5728\u590d\u6742\u5236\u9020\u5feb\u901f\u653e\u91cf\u4e0e\u4f9b\u5e94\u94fe\u672c\u5730\u5316\u65b9\u9762\u7684\u901f\u5ea6\u3002\u751f\u7269\u5236\u836f\u6b63\u9075\u5faa\u8fd9\u4e00\u8def\u5f84\uff0c\u5de5\u7a0b\u6df1\u5ea6\u4e0e\u8fc7\u7a0b\u63a7\u5236\u5982\u4eca\u5df2\u6210\u4e3a\u751f\u7269\u5236\u5242\u4ea7\u7387\u4e0e\u6210\u672c\u7684\u5dee\u5f02\u5316\u56e0\u7d20\u3002<\/p>\n<h3>\u98ce\u9669\u4e0e\u6295\u8d44\u8981\u70b9<\/h3>\n<p>\u5b58\u5728\u9006\u98ce\u3002\u5730\u7f18\u653f\u6cbb\u53ef\u80fd\u91cd\u5851\u6570\u636e\u6d41\u3001\u51fa\u53e3\u7ba1\u5236\u4e0e\u91c7\u8d2d\u6e05\u5355\u3002\u7f8e\u56fd\u7684\u751f\u7269\u5b89\u5168\u5ba1\u67e5\u63d0\u9ad8\u4e86\u5bf9\u4e2d\u56fd CDMO \u7684\u5c3d\u804c\u8c03\u67e5\u6210\u672c\u3002\u56fd\u5185\u62db\u6807\u4e0e NRDL \u66f4\u65b0\u5bf9\u5b9a\u4ef7\u6784\u6210\u538b\u529b\u3002\u7136\u800c\u8fc4\u4eca\u4e3a\u6b62\u7684\u5e94\u5bf9\u662f\u52a1\u5b9e\u4e14\u53ef\u6295\u8d44\u7684\uff1a\u66f4\u591a\u6d77\u5916\u4ea7\u80fd\u3001\u591a\u5143\u5316\u7684\u5ba2\u6237\u57fa\u7840\uff0c\u4ee5\u53ca\u4ece\u4e00\u5f00\u59cb\u5c31\u8bbe\u8ba1\u4ee5\u6ee1\u8db3 FDA \u4e0e EMA \u671f\u671b\u7684\u8d44\u4ea7\u3002\u4e2d\u56fd\u7684\u751f\u7269\u5236\u836f\u5806\u6808\u5df2\u8fbe\u5230\u98de\u8f6e\u65f6\u523b\u2014\u2014\u653f\u7b56\u3001\u8d44\u672c\u3001\u4eba\u624d\u4e0e\u57fa\u7840\u8bbe\u65bd\u76f8\u4e92\u5f3a\u5316\u3002\u7ed3\u679c\u662f\u5927\u91cf\u5177\u5907\u5168\u7403\u843d\u5730\u80fd\u529b\u7684\u8d44\u4ea7\u6d8c\u73b0\uff0c\u4e00\u4e2a\u5982\u4eca\u4e0d\u53ef\u6216\u7f3a\u7684 CDMO \u57fa\u7840\u8bbe\u65bd\uff0c\u4ee5\u53ca\u80fd\u591f\u9ad8\u901f\u8fd0\u884c\u591a\u533a\u57df\u8bd5\u9a8c\u7684\u4e34\u5e8a\u6267\u884c\u673a\u5668\u3002\u5bf9\u4e8e\u5177\u6709\u4e09\u5230\u4e94\u5e74\u89c6\u89d2\u7684\u6295\u8d44\u7ec4\u5408\uff0c\u5e94\u5173\u6ce8\u90a3\u4e9b\u5728\u7f8e\u6b27\u6709\u66dd\u5149\u3001\u5728\u6280\u672f\u8def\u5f84\u4e0a\u5177\u5907\u5e7f\u5ea6\u5e76\u5df2\u8bc1\u660e\u76d1\u7ba1\u6267\u884c\u529b\u7684\u9886\u5bfc\u8005\u3002\u603b\u4f53\u800c\u8a00\uff0c\u4e2d\u56fd\u5b55\u80b2\u91cd\u78c5\u836f\u7269\u7684\u8981\u7d20\u5df2\u5c31\u4f4d\u2014\u2014\u53d1\u73b0\u6df1\u5ea6\u3001\u53ef\u653e\u91cf\u7684\u751f\u7269\u5236\u9020\u3001AI \u6760\u6746\u4ee5\u53ca\u901a\u5f80\u5168\u7403\u5e02\u573a\u7684\u901a\u8def\u3002\u4e0b\u4e00\u7ae0\u8282\u7684\u95ee\u9898\u4e0d\u518d\u662f\u91cd\u78c5\u836f\u7269\u662f\u5426\u6765\u81ea\u4e2d\u56fd\uff0c\u800c\u662f\u4f1a\u6709\u591a\u5c11\u6b3e\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e2d\u56fd\u751f\u7269\u5236\u836f\u884c\u4e1a\u6b63\u5feb\u901f\u6f14\u53d8\uff0c\u65b0\u7684\u653f\u7b56\u6539\u9769\u548c\u57fa\u7840\u8bbe\u65bd\u5efa\u8bbe\u6b63\u5c06China\u5b9a\u4f4d\u4e3a\u6f5c\u5728\u7684\u4e0b\u4e00\u4e2a\u91cd\u78c5\u836f\u7269\u6765\u6e90\uff0c\u5f71\u54cd\u5168\u7403\u5e02\u573a\u5e76\u5e26\u6765\u6295\u8d44\u673a\u4f1a\u3002<\/p>\n","protected":false},"author":49,"featured_media":587496,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[526,766,2350],"class_list":["post-607243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-526","tag-766","tag--2-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/607243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=607243"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/607243\/revisions"}],"predecessor-version":[{"id":607275,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/607243\/revisions\/607275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/587496"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=607243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=607243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=607243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}